chr1-45331733-A-C

Variant names:

• chr1-45331733-A-C
• rs587782261
• NM_001048174.2:c.1030T>G

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 4P and 3B. PM1 PM2 BP4_Moderate BP6

The NM_001048174.2(MUTYH):​c.1030T>G​(p.Ser344Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S344C) has been classified as Likely benign.

• Frequency: Genomes: not found (cov: 33)
• Consequence: MUTYH NM_001048174.2 missense
• Clinical Significance: Uncertain significance criteria provided, multiple submitters, no conflicts U:2
• Conservation: PhyloP100: 1.29
• Publications: 4 publications found

Genes affected

MUTYH (HGNC:7527): (mutY DNA glycosylase) This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017]

MUTYH Gene-Disease associations (from GenCC):

• familial adenomatous polyposis 2

  Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P
• colorectal cancer

  Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
• familial ovarian cancer

  Inheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
• hereditary breast carcinoma

  Inheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen

ENSG00000288208 (HGNC:):

ACMG classification

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

• PM1: In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 23 benign, 51 uncertain in NM_001048174.2
• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (MetaRNN=0.12846619).
• BP6: Variant 1-45331733-A-C is Benign according to our data. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034. Variant chr1-45331733-A-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 651034.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
MUTYH	NM_001048174.2	c.1030T>G	p.Ser344Ala	missense_variant	Exon 12 of 16	ENST00000456914.7	NP_001041639.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
MUTYH	ENST00000456914.7	c.1030T>G	p.Ser344Ala	missense_variant	Exon 12 of 16	1	NM_001048174.2	ENSP00000407590.2
ENSG00000288208	ENST00000671898.1	n.1618T>G		non_coding_transcript_exon_variant	Exon 16 of 21			ENSP00000499896.1

Frequencies

GnomAD3 genomes Cov.: 33

GnomAD4 exome Cov.: 33

GnomAD4 genome Cov.: 33

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Familial adenomatous polyposis 2 Uncertain:1

May 10, 2022

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

ClinVar contains an entry for this variant (Variation ID: 651034). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with MUTYH-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 372 of the MUTYH protein (p.Ser372Ala). -

Hereditary cancer-predisposing syndrome Uncertain:1

Apr 24, 2022

Ambry Genetics

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The p.S372A variant (also known as c.1114T>G), located in coding exon 12 of the MUTYH gene, results from a T to G substitution at nucleotide position 1114. The serine at codon 372 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.084
BayesDel_addAF	Benign	-0.058	T
BayesDel_noAF	Benign	-0.32
CADD	Benign	18
DANN	Benign	0.96
DEOGEN2	Benign	0.036	.;.;.;.;.;T;.;.;.;T
Eigen	Benign	-0.45
Eigen_PC	Benign	-0.25
FATHMM_MKL	Uncertain	0.81	D
LIST_S2	Benign	0.67	.;T;.;T;T;T;T;T;T;T
M_CAP	Benign	0.052	D
MetaRNN	Benign	0.13	T;T;T;T;T;T;T;T;T;T
MetaSVM	Benign	-0.83	T
MutationAssessor	Benign	1.0	.;.;.;.;.;L;.;.;.;.
PhyloP100		1.3
PrimateAI	Benign	0.37	T
PROVEAN	Benign	-0.58	N;N;N;N;N;N;N;N;N;.
REVEL	Benign	0.22
Sift	Benign	0.36	T;T;T;T;T;T;T;T;T;.
Sift4G	Benign	0.63	T;T;T;T;T;T;T;T;T;T
Polyphen		0.0	.;.;.;.;.;B;B;.;B;.
Vest4		0.13
MutPred		0.39		.;.;.;.;.;.;.;.;Loss of glycosylation at S372 (P = 0.0373);.;
MVP		0.84
MPC		0.093
ClinPred		0.17	T
GERP RS		4.6
RBP_binding_hub_radar		0.0
RBP_regulation_power_radar		1.1
Varity_R		0.040
gMVP		0.45
Mutation Taster		=67/33	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.020		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs587782261; hg19: chr1-45797405;